Niran J Amar

GSK Investigational SitePhiladelphia, Pennsylvania - 19106 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS7
- SINCE2010

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
June 2010 - March 2011
Asthma
Placebo
Gsk2190915 30mg
Gsk2190915 300mg
Gsk2190915 100mg
Fluticasone Propionate 100mcg Bd
Gsk2190915 10mg
Montelukast 10mg



